Literature DB >> 7972763

Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities.

B D Ross1, S Jacobson, F Villamil, J Korula, R Kreis, T Ernst, T Shonk, R A Moats.   

Abstract

PURPOSE: To determine whether hydrogen-1 magnetic resonance (MR) spectroscopy of the brain allows detection of subclinical hepatic encephalopathy (SCHE).
MATERIALS AND METHODS: In a double-blind study, overt hepatic encephalopathy (HE) and SCHE (defined with clinical and neuropsychiatric tests) were compared by means of H-1 MR spectroscopic criteria--reduction in cerebral myo-inositol (< 2 standard deviations [SDs] from normal) and choline (< 2 SDs from normal) with or without increased cerebral glutamine (> 1 SD from normal)--in 20 patients with cirrhosis.
RESULTS: Concordance between MR spectroscopic and neuropsychiatric test results was 94% (kappa = 0.84). MR spectroscopy allowed diagnosis of SCHE in nine of nine patients (100%) and of HE in seven of eight (88%). Myo-inositol depletion alone had 80%-85% sensitivity for detection of HE and SCHE.
CONCLUSION: H-1 MR spectroscopy allows accurate diagnosis of SCHE, and the results suggest an important role for myo-inositol in psychomotor and visuopractic functions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972763     DOI: 10.1148/radiology.193.2.7972763

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  50 in total

Review 1.  Hepatic encephalopathy as a complication of liver disease.

Authors:  S vom Dahl; G Kircheis; D Häussinger
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis.

Authors:  A Rovira; E Grivé; S Pedraza; A Rovira; J Alonso
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

Review 3.  The basal ganglia and portal-systemic encephalopathy.

Authors:  K Weissenborn; H Kolbe
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

4.  Vulnerability of welders to manganese exposure--a neuroimaging study.

Authors:  Zaiyang Long; Yue-Ming Jiang; Xiang-Rong Li; William Fadel; Jun Xu; Chien-Lin Yeh; Li-Ling Long; Hai-Lan Luo; Jaroslaw Harezlak; James B Murdoch; Wei Zheng; Ulrike Dydak
Journal:  Neurotoxicology       Date:  2014-03-27       Impact factor: 4.294

Review 5.  Proton magnetic resonance spectroscopy in portal-systemic encephalopathy.

Authors:  H Köstler
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 6.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

7.  Alterations in brain metabolism during the first year of HIV infection.

Authors:  Margaret R Lentz; Woong-Ki Kim; Hyun Kim; Caroline Soulas; Vallent Lee; Nagagopal Venna; Elkan F Halpern; Eric S Rosenberg; Kenneth Williams; R G González
Journal:  J Neurovirol       Date:  2011-04-15       Impact factor: 2.643

Review 8.  Recent advances in magnetic resonance neurospectroscopy.

Authors:  Yael Rosen; Robert E Lenkinski
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 9.  In vivo studies of brain metabolism in animal models of Hepatic Encephalopathy using ¹H Magnetic Resonance Spectroscopy.

Authors:  Cristina Cudalbu
Journal:  Metab Brain Dis       Date:  2012-12-21       Impact factor: 3.584

Review 10.  RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia.

Authors:  Freimut Schliess; Boris Görg; Dieter Häussinger
Journal:  Metab Brain Dis       Date:  2009-01-16       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.